Tumor-Targeting Ability of Novel Anti-Prostate-Specific Membrane Antigen Antibodies
Sign Up to like & getrecommendations! Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.2c04230
Abstract: Patients with prostate-specific membrane antigen (PSMA)-positive tumors can benefit from PSMA-targeted therapy; thus, we have constructed a phage-displayed synthetic antibody library for the production of novel PSMA antibodies with superior PSMA-targeting ability, favoring clinical management.… read more here.
Keywords: prostate specific; targeting ability; membrane antigen; j591 ... See more keywords